TABLE 2.

Correlation analysis between PLA2Rab and clinical parameters in overall cohort, CTX group, and TAC group.

Parameters	Overall cohort		CTX group		TAC group
	CO	p value	CO	p-value	CO	p-value
Age (years)	0.096	0.043	0.034	0.578	0.177	0.020
Male gender	0.039	0.413	0.074	0.223	0.005	0.943
SBP (mmHg)	0.077	0.104	0.039	0.518	0.116	0.129
DBP (mmHg)	0.105	0.027	0.112	0.063	0.090	0.242
Serum creatinine (µmol/L)	0.092	0.052	0.053	0.380	0.150	0.049
eGFR (mL/min/1.73 m2)	−0.110	0.020	−0.047	0.439	−0.194	0.011
TG (mmol/L)	0.122	0.010	0.106	0.080	0.147	0.054
TCHO (mmol/L)	0.110	0.020	0.089	0.142	0.144	0.059
HDL-chol (mmol/L)	−0.051	0.281	−0.041	0.496	−0.078	0.307
LDL-chol (mmol/L)	0.075	0.111	0.106	0.080	0.035	0.653

PLA2Ra, antibodies against the M-type phospholipase-A2-receptor; CTX, cyclophosphamide; TAC, tacrolimus; CO, correlation coefficient; SBP, systolic blood pressure; DBP: diastolic blood pressure; eGFR, estimated glomerular filtration rate; TG, triglyceride; TCHO, total cholesterol; HDL-chol, high-density lipoprotein cholesterol; LDL-chol, low-density lipoprotein cholesterol. p < 0.05 was considered significant difference.